Manulife Investment Management Announces Cash Distributions for Manulife Exchange Traded Funds
C$ unless otherwise stated TSX/NYSE/PSE: MFC SEHK: 945 TORONTO, Nov. 23, 2023 /CNW/ – Manulife Investment Management today announced the November 2023 cash distributions for Manulife Exchange Traded F
Trina Solar on Forbes China Top 50 Innovative Companies List
CHANGZHOU, China, Nov. 23, 2023 /PRNewswire/ — Trina Solar has won a place on the 2023 Forbes China Top 50 Innovative Companies list, Forbes China says. The list, announced on November 9, features the most innovative and burgeoning Chinese companies and pays special attention to corporate R&am
Fainders.AI partners with GS25 to launch an autonomous convenience store in Seoul, South Korea
Fainders.AI has teamed up with GS25, the largest convenience store brand in Korea, to launch an autonomous store in Seoul, South Korea SEOUL, South Korea, Nov. 23, 2023 /PRNewswire/ — The new autonomous convenience store is powered by Fainders.AI’s latest vision AI technology. The latest
Desjardins announces 2023 estimated annual reinvested distributions for Desjardins ETFs
MONTREAL, Nov. 23, 2023 /CNW/ – Desjardins Global Asset Management Inc. (DGAM), acting as manager and portfolio advisor of the Desjardins Exchange Traded Funds (ETFs), announces today the estimated annual reinvested income and/or capital gains distributions (the “reinvested distribution
CIBC Asset Management announces CIBC ETF cash distributions for November 2023
TORONTO, Nov. 23, 2023 /CNW/ – CIBC (TSX: CM) (NYSE: CM) – CIBC Asset Management Inc. today announced the November 2023 cash distributions for CIBC ETFs and ETF Series of the CIBC Fixed Income Pools, which distribute monthly. Unitholders of record on November 30, 2023, will receive cash dist
Ellipses EP0031/A400 granted Orphan Drug Designation from the US Food and Drug Administration
EP0031/A400, a next generation selective RET inhibitor (SRI), is currently being investigated as a treatment option for patients with RET altered tumours LONDON, Nov. 23, 2023 /PRNewswire/ — Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the
Moving towards India@2047: Roadmap to shape the future of pharma and healthcare discussed at OPPI Annual Summit
The theme for this year’s Summit ‘Bharat Ke Liye’ encapsulated its commitment to converge and collaborate with stakeholders to co-create innovative solutions to address the nation’s healthcare challenges NEW DELHI , Nov. 23, 2023 /PRNewswire/ — The Organisation of Phar
Lin-gang Exhibition Area becomes catalyst of international cooperation at CIIE
SHANGHAI, Nov. 23, 2023 /PRNewswire/ — The Sixth China International Import Expo (CIIE) ended on November 10 in Shanghai after six busy and fruitful days. For the first time, the Lin-gang area has taken up a new role as the exhibitor recruitment partner of the Intelligent Industry & Inform
Jazz honoured with Indigenous Reconciliation award from Government of Canada
HALIFAX, NS, Nov. 23, 2023 /CNW/ – Chorus Aviation Inc. (‘Chorus’) (TSX: CHR) is pleased to announce that its subsidiary Jazz Aviation LP (‘Jazz’) has received an inaugural year Indigenous Reconciliation award from the Government of Canada’s Employment Equity Ach
Discover Top iGaming Trends 2024 in SOFTSWISS In-Depth Research
GZIRA, Malta, Nov. 23, 2023 /PRNewswire/ — Players gravitate towards a deeper sense of purpose and community fostered by in-game competition, social interaction, and collaboration – an observation from a survey outlining the 2024 industry trends. Amidst the evolving iGaming landscape, SOFTSW
